<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="01b14603-8f29-4fa3-8d7e-9d523f802e0b"><labelDrug name="Plavix"><Normalization><mmtx cui="C0633084" preferredWord="Plavix" semType="phsu, orch"/></Normalization></labelDrug><generic name="clopidogrel bisulfate"/><sentence id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.1" text="PLAVIX (clopidogrel bisulfate) tablet, film coated" type="negative"><entity charOffset="0:6" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.1.e.0" text="plavix" type="Biomedical_Entity"><Normalization><mmtx cui="C0633084" phraseText="PLAVIX" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="8:29" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.1.e.1" text="clopidogrel bisulfate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772326" phraseText="(clopidogrel bisulfate" preferredWord="Clopidogrel bisulfate" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.1.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.1.e.1"/></sentence><sentence id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.6" text="Plavix is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to clopidogrel or any component of the product [see Adverse Reactions (6.2)]." type="negative"><entity charOffset="0:6" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.6.e.0" text="plavix" type="Biomedical_Entity"><Normalization><mmtx cui="C0633084" phraseText="Plavix" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="83:94" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.6.e.1" text="clopidogrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0070166" phraseText="to clopidogrel" preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.6.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.6.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11" lineNumber="17" text="The metabolism of clopidogrel to its active metabolite can be impaired by genetic variations in CYP2C19 [see Boxed Warning] and by concomitant medications that interfere with CYP2C19." type="regular"><entity charOffset="143:182" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.0" text="medications that interfere with CYP2C19" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="and by concomitant medications" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="691673"/></Normalization></entity><entity charOffset="4:14|30:54|62:70" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.1" text="metabolism to its active metabolite impaired" type="Decrease_Interaction"/><entity charOffset="18:29" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.3" text="clopidogrel" type="Drug"><Normalization><mmtx cui="C0070166" phraseText="The metabolism of clopidogrel" preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.1"><relations><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.3" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.0" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.11.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13" lineNumber="21" text="Avoid concomitant use of Plavix with omeprazole or esomeprazole because both significantly reduce the antiplatelet activity of Plavix [see Drug Interactions (7.1) and Dosage and Administration (2.4)]." type="regular"><entity charOffset="127:133" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.0" text="Plavix" type="Drug"><Normalization><mmtx cui="C0633084" phraseText="the antiplatelet activity of Plavix" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="37:47" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.1" text="omeprazole" type="Drug"><Normalization><mmtx cui="C0028978" phraseText="with omeprazole" preferredWord="Omeprazole" semType="phsu, orch"/><RxNorm RxCui="7646"/></Normalization></entity><entity charOffset="51:63" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.2" text="esomeprazole" type="Drug"><Normalization><mmtx cui="C0937846" phraseText="esomeprazole" preferredWord="Esomeprazole" semType="phsu, orch"/><RxNorm RxCui="283742"/></Normalization></entity><entity charOffset="91:123" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.3" text="reduce the antiplatelet activity" type="Specific_Interaction"/><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.1" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.0" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.0" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.1" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.13.e.2"/></sentence><sentence id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.15" text="Thienopyridines, including Plavix, increase the risk of bleeding. " type="negative"><entity charOffset="27:33" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.15.e.0" text="plavix" type="Biomedical_Entity"><Normalization><mmtx cui="C0633084" phraseText="Plavix," preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="0:15" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.15.e.1" text="thienopyridines" type="Biomedical_Entity"><Normalization><mmtx cui="C1120149" phraseText="Thienopyridines," preferredWord="thienopyridine" semType="phsu, orch"/><RxNorm RxCui="1031667"/></Normalization></entity><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.15.e.1" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.15.e.0"/></sentence><sentence id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.17" text="In patients who stopped therapy more than five days prior to CABG the rates of major bleeding were similar (event rate 4.4% Plavix + aspirin; 5.3% placebo + aspirin). " type="negative"><entity charOffset="157:164" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.17.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="; 5.3% placebo + aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="133:140" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.17.e.1" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="(event rate 4.4% Plavix + aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="124:130" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.17.e.2" text="plavix" type="Biomedical_Entity"><Normalization><mmtx cui="C0633084" phraseText="(event rate 4.4% Plavix + aspirin" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.17.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.17.e.0"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.17.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.17.e.1"/></sentence><sentence id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.18" text="In patients who remained on therapy within five days of CABG, the major bleeding rate was 9.6% for Plavix + aspirin, and 6.3% for placebo + aspirin." type="negative"><entity charOffset="108:115" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.18.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="9.6% for Plavix + aspirin," preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="99:105" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.18.e.1" text="plavix" type="Biomedical_Entity"><Normalization><mmtx cui="C0633084" phraseText="9.6% for Plavix + aspirin," preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="140:147" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.18.e.2" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="6.3% for placebo + aspirin." preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.18.e.1" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.18.e.0"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.18.e.1" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.18.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26" lineNumber="35" text="In patients with recent TIA or stroke who are at high risk for recurrent ischemic events, the combination of aspirin and Plavix has not been shown to be more effective than Plavix alone, but the combination has been shown to increase major bleeding." type="regular"><entity charOffset="240:248" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.0" text="bleeding" type="Specific_Interaction"/><entity charOffset="109:116" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="the combination of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="121:127" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.3" text="Plavix" type="Drug"><Normalization><mmtx cui="C0633084" phraseText="Plavix" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.0"><relations><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.3" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.26.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34" lineNumber="45" text="Concomitant use of certain drugs that inhibit the activity of this enzyme results in reduced plasma concentrations of the active metabolite of clopidogrel and a reduction in platelet inhibition [see Warnings and Precautions (5.1) and Dosage and Administration (2.4)]." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.33" Text="Clopidogrel is metabolized to its active metabolite in part by CYP2C19. "/><anaphoraEntity charOffset="62:73" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.1" text="this enzyme" type="Expression"/><antecedentEntity charOffset="63:70" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.33.e.0" text="CYP2C19" type="Substance"/></anaphoraRelation><entity charOffset="27:73" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.0" text="drugs that inhibit the activity of this enzyme" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Concomitant use of certain drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="85:114" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.3" text="reduced plasma concentrations" type="Decrease_Interaction"/><entity charOffset="143:154" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.5" text="clopidogrel" type="Drug"><Normalization><mmtx cui="C0070166" phraseText="results in reduced plasma concentrations of the active metabolite of clopidogrel" preferredWord="clopidogrel" semType="phsu, orch"/><mmtx cui="C0070166" phraseText="results in reduced plasma concentrations of the active metabolite of clopidogrel" preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><entity charOffset="161:193" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.6" text="reduction in platelet inhibition" type="Specific_Interaction"/><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.3"><relations><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.ddi.2"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.6"><relations><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.5" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.34.e.3" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36" lineNumber="49" text="Avoid concomitant use of Plavix with omeprazole or esomeprazole. " type="regular"><entity charOffset="25:31" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.0" text="Plavix" type="Drug"><Normalization><mmtx cui="C0633084" phraseText="concomitant use of Plavix" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="37:47" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.1" text="omeprazole" type="Drug"><Normalization><mmtx cui="C0028978" phraseText="with omeprazole" preferredWord="Omeprazole" semType="phsu, orch"/><RxNorm RxCui="7646"/></Normalization></entity><entity charOffset="51:63" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.2" text="esomeprazole" type="Drug"><Normalization><mmtx cui="C0937846" phraseText="esomeprazole." preferredWord="Esomeprazole" semType="phsu, orch"/><RxNorm RxCui="283742"/></Normalization></entity><entity charOffset="0:5" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.3" text="Avoid" type="Caution_Interaction"/><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.1" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.3" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.2" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.3" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.1" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.36.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37" lineNumber="49" text="In clinical studies, omeprazole was shown to reduce the antiplatelet activity of Plavix when given concomitantly or 12 hours apart. " type="regular"><entity charOffset="21:31" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.0" text="omeprazole" type="Drug"><Normalization><mmtx cui="C0028978" phraseText="omeprazole" preferredWord="Omeprazole" semType="phsu, orch"/><RxNorm RxCui="7646"/></Normalization></entity><entity charOffset="45:77" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.1" text="reduce the antiplatelet activity" type="Specific_Interaction"/><entity charOffset="81:87" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.3" text="Plavix" type="Drug"><Normalization><mmtx cui="C0633084" phraseText="the antiplatelet activity of Plavix" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.3" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.37.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38" lineNumber="49" text="A higher dose regimen of clopidogrel concomitantly administered with omeprazole increases antiplatelet response; " type="regular"><entity charOffset="25:36" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.0" text="clopidogrel" type="Drug"><Normalization><mmtx cui="C0070166" phraseText="A higher dose regimen of clopidogrel concomitantly" preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><entity charOffset="69:79" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.1" text="omeprazole" type="Drug"><Normalization><mmtx cui="C0028978" phraseText="administered with omeprazole" preferredWord="Omeprazole" semType="phsu, orch"/><RxNorm RxCui="7646"/></Normalization></entity><entity charOffset="80:111" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.2" text="increases antiplatelet response" type="Specific_Interaction"/><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.1" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.38.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40" lineNumber="49" text="A similar reduction in antiplatelet activity was observed with esomeprazole when given concomitantly with Plavix. " type="regular"><entity charOffset="63:75" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.0" text="esomeprazole" type="Drug"><Normalization><mmtx cui="C0937846" phraseText="observed with esomeprazole" preferredWord="Esomeprazole" semType="phsu, orch"/><RxNorm RxCui="283742"/></Normalization></entity><entity charOffset="106:112" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.1" text="Plavix" type="Drug"><Normalization><mmtx cui="C0633084" phraseText="concomitantly with Plavix." preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="10:44" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.2" text="reduction in antiplatelet activity" type="Specific_Interaction"/><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.1" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.40.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42" lineNumber="49" text="Dexlansoprazole, lansoprazole and pantoprazole had less effect on the antiplatelet activity of Plavix than did omeprazole or esomeprazole [see Dosage and Administration (2.4), Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)]." type="regular"><entity charOffset="56:91" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.0" text="effect on the antiplatelet activity" type="Specific_Interaction"/><entity charOffset="0:15" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.2" text="Dexlansoprazole" type="Drug"><Normalization><mmtx cui="C2348248" phraseText="Dexlansoprazole," preferredWord="dexlansoprazole" semType="phsu, orch"/><RxNorm RxCui="816346"/></Normalization></entity><entity charOffset="17:29" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.3" text="lansoprazole" type="Drug"><Normalization><mmtx cui="C0050940" phraseText="lansoprazole" preferredWord="lansoprazole" semType="phsu, orch"/><RxNorm RxCui="17128"/></Normalization></entity><entity charOffset="34:46" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.4" text="pantoprazole" type="Drug"><Normalization><mmtx cui="C0081876" phraseText="pantoprazole" preferredWord="pantoprazole" semType="phsu, orch"/><RxNorm RxCui="40790"/></Normalization></entity><entity charOffset="95:101" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.5" text="Plavix" type="Drug"><Normalization><mmtx cui="C0633084" phraseText="less effect on the antiplatelet activity of Plavix" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="111:121" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.6" text="omeprazole" type="Drug"><Normalization><mmtx cui="C0028978" phraseText="omeprazole" preferredWord="Omeprazole" semType="phsu, orch"/><RxNorm RxCui="7646"/></Normalization></entity><entity charOffset="125:137" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.7" text="esomeprazole" type="Drug"><Normalization><mmtx cui="C0937846" phraseText="esomeprazole" preferredWord="Esomeprazole" semType="phsu, orch"/><RxNorm RxCui="283742"/></Normalization></entity><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.3" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.5" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.5" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.5" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.6" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.5" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.7" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.4" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.5" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.3"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.3" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.6"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.3" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.7"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.3" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.4"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.6"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.7"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.2" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.4"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.6" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.7"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.4" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.6"/><pair ddi="false" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.4" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.42.e.7"/></sentence><sentence biomedicalEntities="2" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44" lineNumber="53" text="Coadministration of Plavix and NSAIDs increases the risk of gastrointestinal bleeding." type="regular"><entity charOffset="20:26" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.0" text="Plavix" type="Drug"><Normalization><mmtx cui="C0633084" phraseText="Coadministration of Plavix" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="31:37" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.1" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="60:85" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.2" text="gastrointestinal bleeding" type="Specific_Interaction"/><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.1" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.44.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46" lineNumber="57" text="Although the administration of clopidogrel 75 mg per day did not modify the pharmacokinetics of S-warfarin (a CYP2C9 substrate) or INR in patients receiving long-term warfarin therapy, coadministration of Plavix with warfarin increases the risk of bleeding because of independent effects on hemostasis." type="regular"><entity charOffset="205:211" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.0" text="Plavix" type="Drug"><Normalization><mmtx cui="C0633084" phraseText="coadministration of Plavix" preferredWord="Plavix" semType="phsu, orch"/><RxNorm RxCui="174742"/></Normalization></entity><entity charOffset="217:225" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.1" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="with warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="248:256" id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.2" text="bleeding" type="Specific_Interaction"/><drugInteraction id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.ddi.1"><interaction trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.2"><relations><relation type="hasObject"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.0" e2="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.1" trigger="Dailymed.01b14603-8f29-4fa3-8d7e-9d523f802e0b.s.46.e.2" type="Specific_Interaction"/></sentence><positiveExamples number="17"/><negativeExamples number="19"/></document>